ADC Therapeutics(ADCT) - 2025 Q4 - Earnings Call Presentation

4Q FY 2025 Earnings Call March 10, 2026 Agenda 01 Business Update Ameet Mallik Chief Executive Officer 02 Financial Update Pepe Carmona Chief Financial Officer 03 Q&A 2 Forward-Looking Statements This presentation and any accompanying oral presentation have been prepared by ADC Therapeutics SA ("ADC Therapeutics", "we" or "us") for informational purposes only and not for any other purpose. Nothing contained in this presentation is, or should be construed as, a recommendation, promise or representation by th ...